In a Norwegian study of the general population, individuals with metabolic syndrome were more likely to have renal hyperfiltration and experience steeper long-term declines in glomerular filtration rate.
Your search for cardiovascular disease returned 979 results
Click on a filter below to refine your search. Remove a filter to broaden your search.
Researchers investigated the risk for diabetes among patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs.
Study findings showed a marked elevation in the risks of cardiovascular outcomes in patients with deteriorating kidney function.
Investigators assessed risks for major adverse cardiovascular events among patients with rheumatoid arthritis treated with opioids vs nonsteroidal anti-inflammatory drugs.
Investigators assessed the impact of a recent 2019 label change on the use of febuxostat among patients with gout.
Increase in biomarkers and multimarker panel linked to increased risk for primary cardiorenal outcome
Hyperuricemia may contribute to heart failure risk via increased oxidative stress, endothelial dysfunction, inflammation, and insulin resistance, according to investigators.
Findings seen for all-cause death and cardiovascular mortality
Home blood pressure monitoring can reduce the burden of cardiovascular disease and reduce health care costs.
Higher risk also seen for subsequent risks of undergoing aortic valve intervention and having aortic stenosis-related death
Investigators assessed the prevalence and predictors of cardiovascular risk factors and diseases among patients with primary Sjögren syndrome and aimed to develop a standard procedure for risk evaluation in clinical practice settings.
The choice and dosage of drugs may need to be modified when treating gout in patients with chronic kidney disease.
A study was conducted to determine the effect of NSAIDs on cardiovascular risk factors following first-time myocardial infarction or heart failure.
Researchers examined long-term associations between COVID-19 infection and the risk of mortality and multiorgan complications among older adults.
A healthy diet, including whole-fat dairy, is associated with lower risk of mortality and cardiovascular disease.
Polypill therapy for cardiovascular disease may help address some barriers to care and health care disparities.
Canadian wildfire smoke seen throughout the US this wildfire season highlights the importance of protecting lung health as climate change unfolds.
Investigators compared sodium-glucose cotransporter-2 inhibitors (SGLT2i) and dipeptidyl peptidase 4 inhibitors (DPP-4is) in a propensity-score matched group of patients with gout and type 2 diabetes.
Study findings suggest clinicians may safely prescribe alpha blockers to help manage hypertension in patients receiving hemodialysis.
Investigators evaluated patients newly diagnosed with rheumatoid arthritis for cardiovascular disease risk and assessed their adherence to preventative medical treatment following screening.
The American Heart Association issued a statement regarding cardiovascular disease risk in Asian American adult patients.
RA is associated with an increased risk for cardiovascular disease and mortality.
A large-scale study testing the safety of the anti-inflammatory colchicine in treating long-term cardiovascular disease has shown positive results.
The increased rates of cardiovascular disease and cardiovascular mortality associated with ankylosing spondylitis highlight the need for clinicians to monitor patients and manage their cardiovascular risk.
This study finds that a cardiovascular disease prevention counseling program decreases the prevalence of cardiovascular disease risk factors in patients with systemic lupus erythematosus.
Supplementation of some micronutrients may reduce cardiovascular disease (CVD) outcomes.
The risk for cardiovascular disease is grossly underestimated and may account for the disproportionately high percentage of cardiovascular-related deaths in this population.
Individuals with autoimmune disease have an increased risk for developing incident cardiovascular disease.
An overview of the increased risk for cardiovascular disease in patients with systemic lupus erythematosus.